JAK2 and neoplasm: As an extension of our previously established conceptual framework, in which PTPRO downregulates tyrosine phosphorylation of multiple oncogenic pathways in breast carcinogenesis, we experimentally confirmed the functional association between PTPRO phosphatase activity and the JAK2–YAP axis.